📰 Looking Statement News
Page 66 - Looking Statement News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Looking Statement. Real-time updates on events, politics, business and more.
February 8, 2022
08.02.2022 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that a total of approximately 3.1 million courses of molnupiravir, an investigational oral antiviral COVID-19 medicine, have been ...
February 5, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
February 4, 2022
04.02.2022 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Dr. Dean Li, executive vice president and president, Merck Research Laboratories, is scheduled to participate in a virtual fireside chat at the Guggenheim ...
January 31, 2022
SAN JOSE, CA / ACCESSWIRE / January 31, 2022 / Avidbank Holdings, Inc. ("the Company") (OTC PINK:AVBH), a bank holding company and the parent company of Avidbank ("the Bank"), an independent full-service
January 27, 2022
KEYTRUDA Is Now Approved as Monotherapy for Adults With RCC at Increased Risk of Recurrence Following Nephrectomy, or Following Nephrectomy and Resection of Metastatic Lesions KEYTRUDA Is the First
January 26, 2022
/PRNewswire/ -- blueharbor bank (the "Bank") today reported net income of $1,232,123 and $0.41 per diluted share for the fourth quarter of 2021, an increase of...
January 25, 2022
Merck Provides U.S. and Japan Regulatory Update for Gefapixant - read this article along with other careers information, tips and advice on BioSpace
January 24, 2022
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has issued a Com
January 20, 2022
LAS VEGAS, NV / ACCESSWIRE / January 20, 2022 / Cytta Corp (OTCQB:CYCA, the "Company") is pleased to announce that Cytta has engaged Boustead Securities, LLC ("Boustead") to assist with the next phase
January 19, 2022
/PRNewswire/ -- Regulated information – Inside information – UCB (Euronext: UCB) and Zogenix (NASDAQ: ZGNX) announced today that the companies have entered...